 Adaptive Biotechnologies Corporation NASDAQ:ADPT Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - Co-Founder, CEO Tycho Peterson - CFO Harlan Robins - Chief Scientific Officer Nitin Sood - Head of MRD Sharon Benzeno - Head, Immune Medicine Conference Call Participants David Westenberg - Piper Sandler Operator Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Third Quarter Financial Results Conference Call. 